For Patients
The goal of IMMUcan is to understand, how the immune system and tumours interact, and the impact of therapeutic interventions.
What is IMMUcan?
IMMUcan is a group of university and industry partners that collects tumour material and clinical data from several thousand cancer patients. The group generates biological data for research that is being made available for the scientific community.
Many opportunities for collaboration
What are the benefits for patients?
What are the benefits for patients?
01. |
Receive additional information
|
02. |
Contribute to improving our understanding of cancer. |
03. |
Have a major impact on current and future treatments. |
“IMMUcan stands for “Integrated iMMUnoprofiling
of large adaptive CANcer patient cohorts”
What is the aim of IMMUcan?
The tumour microenvironment consists of cancer cells, and other various non-tumour cells that are directly in or around the tumour, such as immune cells. The cancer research community believes that many factors within this environment influence how the tumour reacts to cancer treatments.
The hope is
What will IMMUcan deliver?
IMMUcan will deliver an understanding of the tumour microenvironment and how it evolves under the influence of cancer treatment, using tumour samples from some 3000 patients combined with clinical data.
Samples will include the tumour, stool, saliva or blood from patients diagnosed with colorectal, lung, head and neck, breast or renal cancers.
Why be part of IMMUcan?
By taking part in this project your clinician will receive additional information on your tumour. However, we cannot guarantee that this will have an immediate benefit for you. BUT Your participation can help us better understand cancer and have a major impact on current and future treatments.